GGrantIndex
← Search

TARGETING EXTRACELLULAR NUCLEOSIDE METABOLISM AS A STRATEGY TO POTENTIATE THE EFFECTS OF IMMUNOTHERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA

$602,814FY2024Defense Health AgencyDOD

Board Of Regents Of The University Of Nebraska

Investigators

View source on USAspending →
TARGETING EXTRACELLULAR NUCLEOSIDE METABOLISM AS A STRATEGY TO POTENTIATE THE EFFECTS OF IMMUNOTHERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA · GrantIndex